Page last updated: 2024-09-05
sb 216763 and azd2858
sb 216763 has been researched along with azd2858 in 2 studies
Compound Research Comparison
| Studies (sb 216763) | Trials (sb 216763) | Recent Studies (post-2010) (sb 216763) | Studies (azd2858) | Trials (azd2858) | Recent Studies (post-2010) (azd2858) |
|---|---|---|---|---|---|
| 342 | 0 | 225 | 8 | 0 | 8 |
Protein Interaction Comparison
| Protein | Taxonomy | sb 216763 (IC50) | azd2858 (IC50) |
|---|---|---|---|
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 0.005 | |
| Glycogen synthase kinase-3 beta | Mus musculus (house mouse) | 0.076 |
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Berg, S; Bergh, M; Bhat, R; Hellberg, S; Högdin, K; Jerning, E; Lo-Alfredsson, Y; Neelissen, J; Nilsson, Y; Ormö, M; Söderman, P; Tucker, J; von Berg, S; Weigelt, T; Xue, Y | 1 |
| Feng, F; Jiang, X; Liu, X; Sun, H; Wang, Y; Xu, J; Xu, K; Zhou, J | 1 |
Other Studies
2 other study(ies) available for sb 216763 and azd2858
| Article | Year |
|---|---|
Discovery of novel potent and highly selective glycogen synthase kinase-3β (GSK3β) inhibitors for Alzheimer's disease: design, synthesis, and characterization of pyrazines.
Topics: 3T3 Cells; Alzheimer Disease; Animals; Blood-Brain Barrier; Caco-2 Cells; Cattle; Crystallography, X-Ray; Drug Design; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Mice; Models, Molecular; Molecular Structure; Permeability; Phosphorylation; Pyrazines; Solubility; Sulfonamides; tau Proteins | 2012 |
PROTACs suppression of GSK-3β, a crucial kinase in neurodegenerative diseases.
Topics: Animals; Enzyme Inhibitors; Glycogen Synthase Kinase 3 beta; HT29 Cells; Humans; Models, Molecular; Neurodegenerative Diseases; PC12 Cells; Proteolysis; Rats; Small Molecule Libraries | 2021 |